A systematic review highlights the potential of genomic tests in prostate cancer treatment decisions but calls for more data ...

The Caribbean “took a bold step toward precision medicine with the official launch of the Caribbean Prostate Cancer Genetic ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Incorporating biomarkers into standard practice enhances diagnostic accuracy, supporting confident treatment decisions and optimizing care.

A multicenter prospective study found no link between a high polygenic risk score for rheumatoid arthritis and increased toxicities from cancer radiotherapy.

For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influen ...

A Bermudian genome researching organisation helped to unveil a project designed to pinpoint the genetic factors that make ...

Physicians in the field of urology have advised men, particularly those of African descent to stop attributing the cause of prostate cancer to spiritual-spiritual attacks, which they said were ...

Funded by Prostate Cancer UK, the ICR team focused on genes involved in the PI3K-AKT pathway, which is frequently mutated in ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

When Peter Schweizer was eyeing up his 50th birthday he decided the time had come to focus on getting fit and healthy. The ...